chr19-6690971-C-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000064.4(C3):​c.3391-244G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 152,022 control chromosomes in the GnomAD database, including 1,010 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.11 ( 1010 hom., cov: 32)

Consequence

C3
NM_000064.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.113

Publications

9 publications found
Variant links:
Genes affected
C3 (HGNC:1318): (complement C3) Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015]
C3 Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome with C3 anomaly
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • complement component 3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine
  • C3 glomerulonephritis
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-6690971-C-G is Benign according to our data. Variant chr19-6690971-C-G is described in ClinVar as Benign. ClinVar VariationId is 1178537.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C3NM_000064.4 linkc.3391-244G>C intron_variant Intron 26 of 40 ENST00000245907.11 NP_000055.2 P01024V9HWA9B4DR57

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C3ENST00000245907.11 linkc.3391-244G>C intron_variant Intron 26 of 40 1 NM_000064.4 ENSP00000245907.4 P01024

Frequencies

GnomAD3 genomes
AF:
0.105
AC:
16008
AN:
151910
Hom.:
1009
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0559
Gnomad AMI
AF:
0.156
Gnomad AMR
AF:
0.0997
Gnomad ASJ
AF:
0.182
Gnomad EAS
AF:
0.0756
Gnomad SAS
AF:
0.0789
Gnomad FIN
AF:
0.175
Gnomad MID
AF:
0.0541
Gnomad NFE
AF:
0.125
Gnomad OTH
AF:
0.119
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.105
AC:
16018
AN:
152022
Hom.:
1010
Cov.:
32
AF XY:
0.106
AC XY:
7883
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.0559
AC:
2318
AN:
41494
American (AMR)
AF:
0.0995
AC:
1518
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.182
AC:
631
AN:
3472
East Asian (EAS)
AF:
0.0752
AC:
389
AN:
5174
South Asian (SAS)
AF:
0.0797
AC:
384
AN:
4820
European-Finnish (FIN)
AF:
0.175
AC:
1844
AN:
10542
Middle Eastern (MID)
AF:
0.0582
AC:
17
AN:
292
European-Non Finnish (NFE)
AF:
0.125
AC:
8524
AN:
67958
Other (OTH)
AF:
0.119
AC:
251
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
696
1393
2089
2786
3482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.114
Hom.:
145
Bravo
AF:
0.0991
Asia WGS
AF:
0.0800
AC:
279
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
4.1
DANN
Benign
0.50
PhyloP100
0.11
PromoterAI
0.0026
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3745565; hg19: chr19-6690982; API